{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/124342428"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "But in Friday's split decision, the U.S. Court of Appeals for the Federal Circuit expanded that safe harbor to any use, including post-approval, that is reasonably related to the development and submission of information under a federal law which regulates the manufacture, use or sale of drugs.The decision sinks the long-held notion that once regulatory approval was granted by the FDA, the safe" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "bioworld.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/501863606"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/124342428"] } } }
